ConMed Grows Above Market on Leadership Continuity and New Products
ConMed’s sports medicine business grew in the high single digits in 3Q19, driven by continuity of its leadership team and new product introductions. Nov 01, 2019
Alphatec Spine Continues Success Story with New Product Launches and a Revitalized Sales Channel
Alphatec continued its run of double-digit growth in 3Q19 on the strength of an aggressive new product launch schedule and a revitalized sales channel. Nov 01, 2019
Spinal Implant Growth Drives SeaSpine to Record Revenues
SeaSpine recorded the highest revenue in company history in 3Q19, driven by the Shoreline and Mariner implant systems as well as OsteoStrand Plus DBM. Oct 31, 2019
Stryker Continues to Outpace Competitors with Solid Execution Across Segments
Except for some challenges with the K2M integration, Stryker once again executed at a high level across all segments in 3Q19. Oct 30, 2019
Orthofix Weighed Down by Management Vacancies and Order Delays
Biologics and the M-6 cervical disc sales were bright spots, but Orthofix faced a “perfect storm” of challenges in 3Q19 that will carry through to 2020. Oct 29, 2019
Episurf Continues to Gather Clinical Evidence During Early Commercialization Efforts
Episurf continued to focus on gathering clinical evidence during its early commercialization efforts in 3Q19. Sales grew 13.4% on orders from Germany. Oct 28, 2019
Anika Therapeutics Transforms to Hybrid Commercial Model
In 3Q19, Anika completed the buildout of their U.S. hybrid commercial model while achieving double-digit revenue growth driven by MONOVISC and CINGAL. Oct 25, 2019
Integra LifeSciences Sees Modest Orthopedic Growth from Dedicated Sales Channel
A dedicated sales channel and new products brought low single-digit orthopedic growth to Integra LifeSciences in 3Q19, driven by ankle and shoulder sales. Oct 25, 2019
Safe Orthopaedics Grows 40% in 3Q19 on Indirect Sales Distributors
Safe Orthopaedics achieved record growth in 3Q19 on the strength of distributors and partnerships in Japan that grew indirect sales by 124%. Oct 15, 2019
DePuy Synthes Up 1.2% in 3Q19 on Trauma Growth
DePuy Synthes made modest progress in the quarter with strong trauma sales but lost US spine and knee share to competitors. Oct 15, 2019
